Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists Read more
Particle Sciences Expands Controlled Substance Capabilities with Approval of DEA Schedule I Read more
Merz Pharma: Xeomin (incobotulinumtoxinA) Receives European Approval for Treatment of Chronic Sialorrhea in Adults Read more
Bayer and Foundation Medicine announce global collaboration to develop NGS-based companion diagnostics in oncology Read more
Allergan and Gedeon Richter Receive FDA Approval For Expanded Use of VRAYLAR (cariprazine) in the Treatment of Bipolar Depression Read more
Modulus Discovery Announces Signing of Research Data Transfer Agreement with Astellas Pharma Read more